Brokers name 3 ASX shares to buy today

Brokers are bullish on these ASX shares…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

It has been another busy week for Australia's top brokers. This has led to the release of a large number of broker notes.

Three broker buy ratings that you might want to know more about are summarised below. Here's why brokers think these ASX shares are in the buy zone:

ASX shares Business man marking buy on board and underlining it

Image Source: Getty Images

AVITA Medical Inc (ASX: AVH)

According to a note out of Bell Potter, its analysts have retained their buy rating and $9.80 price target on this regenerative medicine company's shares. This follows news that the US Centre for Medicare has approved a new reimbursement code that will provide separate payment for AVITA's Recell devices used in the outpatient setting. Bell Potter feels this represents an important breakthrough for the company and further validation of the clinical benefit of the Recell technology. It notes that this new code is only granted to devices that offer a substantial clinical improvement over the standard of care. The AVITA share price is trading at $5.12 today.

Hipages Group Holdings Ltd (ASX: HPG)

A note out of Goldman Sachs reveals that its analysts have retained their buy rating and lifted their price target on this tradie platform provider's shares to $4.90. This follows news that the company has acquired a 25% interest in property management technology platform, Bricks + Agent. Goldman notes that this gives Hipages exposure to the A$21 billion Residential and Commercial Property Management channel. Goldman also expects the investment to expand Hipages' ability to capture a greater share of tradie spend. The Hipages share price is fetching $4.02 on Friday.

Suncorp Group Ltd (ASX: SUN)

Analysts at Citi have upgraded this banking and insurance giant's shares to a buy rating with a $12.80 price target. The broker notes that Suncorp's hazards claims have overrun in FY 2022. This has led to the broker downgrading its earnings estimates for the current financial year. However, Citi remains positive in the medium term and believes recent share price weakness has left its shares trading at an attractive level. The Suncorp share price is trading at $11.51 this afternoon.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of and has recommended Avita Medical Limited and Hipages Group Holdings Ltd. The Motley Fool Australia has recommended Avita Medical Limited and Hipages Group Holdings Ltd. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Broker Notes

Businessman working and using Digital Tablet new business project finance investment at coffee cafe.
Broker Notes

Buy, hold, sell: Cochlear, South32, and Westpac shares

Analysts have given their verdict on these popular shares.

Read more »

A young man goes over his finances and investment portfolio at home.
Broker Notes

Buy, hold, sell: ANZ, Breville, and Macquarie shares

Is Morgans bullish or bearish on these shares in April? Let's find out.

Read more »

A man holding a cup of coffee puts his thumb up and smiles while at laptop.
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

Man sitting in a plane seat works on his laptop.
Broker Notes

Down 34% in 2026, are Virgin Australia shares a good buy today?

A leading analyst delivers his outlook for Virgin Australia’s beaten-down shares.

Read more »

Red buy button on an Apple keyboard with a finger on it.
Broker Notes

Brokers name 3 ASX shares to buy right now

Here's why brokers are feeling bullish about these three shares this week.

Read more »

A smiling woman holds a Facebook like sign above her head.
Broker Notes

Why these ASX shares are rated as buys in April

Let's see what makes them bullish on these names right now.

Read more »

Australian dollar notes in the pocket of a man's jeans, symbolising dividends.
Broker Notes

Are CBA shares still a good buy for passive income?

A leading analyst delivers his verdict on CBA’s passive income appeal.

Read more »

A financial expert or broker looks worried as he checks out a graph showing market volatility.
Broker Notes

Morgans names 2 ASX shares to buy and 1 to accumulate

What is the broker recommending investors do with these shares?

Read more »